Tumor Anti-angiogenesis: Nano-Arsenal will Kill the Crab
Future Health · 2023
DOI: 10.25259/fh_20230101_79 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Health, 2023. Verfasst von Feroz Alam und 3 weiteren Autor:innen. Die Arbeit nennt 87 Literaturangaben.
Abstract (Originalsprache)
Angiogenesis: the process of developing new blood vessels from the pre-existing ones is a very crucial process in tumor formation, growth, progression and metastasis. The central role of angiogenesis in tumor growth and progression compels targeting tumor vasculature as a therapeutic mean. Nanoparticles have revolutionized the domain of cancer therapeutics, molecularly targeted anti-cancer drugs represents one of the most significant recent advances in clinical oncology. Various types of nano-drug complexes which targets tumor vasculature preferentially, are being increasingly tested for optimal therapeutic efficacy and minimal side-effects. Here, we review some of these anti-angiogenic nano-drug complexes.
Zitieren
APA
Alam, F., Akhtar, K., Maheshwari, V., & Hasan, M. (2023). Tumor Anti-angiogenesis: Nano-Arsenal will Kill the Crab. Future Health. https://doi.org/10.25259/fh_20230101_79
Vancouver
Alam F, Akhtar K, Maheshwari V, Hasan M. Tumor Anti-angiogenesis: Nano-Arsenal will Kill the Crab. Future Health. 2023. doi:10.25259/fh_20230101_79
BibTeX
@article{Alam2023,
author = {Alam, Feroz and Akhtar, Kafil and Maheshwari, Veena and Hasan, Mahboob},
title = {Tumor Anti-angiogenesis: Nano-Arsenal will Kill the Crab},
journal = {Future Health},
year = {2023},
doi = {10.25259/fh_20230101_79}
}
EUVIMED